Research Article
Preoperative Serum IL-12p40 Is a Potential Predictor of Kasai Portoenterostomy Outcome in Infants with Biliary Atresia
Table 1
Demographic, clinical, and laboratory characteristics of the studied patients.
| Characteristics | BA () | Neglected BA () | Non-BA () | value |
| Age at liver biopsy (days) | 56.56 ± 11.55 | 141.05 ± 60.69 | 57.60 ± 18.90 | <0.0001 | Male, n (%) | 14 (56) | 9 (45) | 16 (53.3) | 0.75 | Clay stool | 25 (100) | 20 (100) | 10 (33.3) | <0.0001 | Hepatomegaly (US) | 25 (100) | 19 (95) | 38 (93.3) | 0.438 | Splenomegaly (US) | 16 (64) | 16 (80) | 16 (53.3) | 0.157 | Ascites (US) | 0 (0.0) | 4 (20) | 1 (3.3) | 0.018 | Total bilirubin (mg/dl) | 11.32 ± 4.1 | 12.12 ± 4.23 | 10.77 ± 4.75 | 0.424 | Direct bilirubin (mg/dl) | 7.74 ± 3.48 | 9.08 ± 3.92 | 7.72 ± 4.22 | 0.29 | Alanine transaminase (U/l) | 141.86 ± 129.95 | 149.2 ± 114.16 | 168.37 ± 112.91 | 0.465 | Aspartate transaminase (U/l) | 200.04 ± 129.69 | 274.15 ± 197.89 | 347.0 ± 258.97 | 0.058 | Albumin (g/dl) | 3.69 ± 0.46 | 3.23 ± 0.62 | 3.5 ± 0.69 | 0.11 | Alkaline phosphatase (U/l) | 568.68 ± 300.02 | 738.0 ± 349.57 | 725.37 ± 359.18 | 0.092 | Gamma-glutamyl transpeptidase (U/l) | 1066.28 ± 762.45 | 832.2 ± 634.82 | 223.53 ± 265.61 | <0.0001 | Prothrombin time (sec) | 12.42 ± 1.65 | 14.36 ± 2.46 | 14.45 ± 6.73 | 0.017 |
|
|
BA: biliary atresia.
|